BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2498022)

  • 1. Vitamin D in Paget's disease of bone.
    Foldes J; Shamir S; Kidroni G; Menczel J
    Clin Orthop Relat Res; 1989 Jun; (243):275-9. PubMed ID: 2498022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
    Menaa C; Barsony J; Reddy SV; Cornish J; Cundy T; Roodman GD
    J Bone Miner Res; 2000 Feb; 15(2):228-36. PubMed ID: 10703924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D status in Paget's bone disease. Effects of calcitonin therapy.
    Nunziata V; Giannattasio R; di Giovanni G; Lettera AM; Nunziata CA
    Clin Orthop Relat Res; 1993 Aug; (293):366-71. PubMed ID: 8339504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What do we know about the significance of vitamin D in Paget's disease of the bone?].
    Wilczek H; Stĕpán J; Justová V
    Cas Lek Cesk; 1995 Dec; 134(24):785-7. PubMed ID: 8599821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etidronic acid therapy in Paget's disease of bone].
    Holz G; Delling G; Ziegler R
    Dtsch Med Wochenschr; 1983 Dec; 108(51-52):1954-8. PubMed ID: 6418505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal vitamin D metabolism in Paget's disease of bone.
    Guillard-Cumming DF; Beard DJ; Douglas DL; Johnson SK; Lawson-Matthew PJ; Russell RG; Kanis JA
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):559-66. PubMed ID: 3872746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of Paget's disease with the combined administration of calcitonin and disodium etidronate].
    Ghiringhelli G; Fogel M; Varela de Rodríguez J; Casco C; Mautelén C; Nusimovich B
    Medicina (B Aires); 1982; 42(1):16-20. PubMed ID: 6813634
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
    Nuti R; Turchetti V; Righi G; Vattimo A
    Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic human calcitonin in refractory Paget's disease of bone.
    Altman RD; Collins-Yudiskas B
    Arch Intern Med; 1987 Jul; 147(7):1305-8. PubMed ID: 3111398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
    Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
    [No Abstract]   [Full Text] [Related]  

  • 14. Contrasting effects of intravenous and oral etidronate on vitamin D metabolism in man.
    Lawson-Matthew PJ; Guilland-Cumming DF; Yates AJ; Russell RG; Kanis JA
    Clin Sci (Lond); 1988 Jan; 74(1):101-6. PubMed ID: 3123117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
    Oreopoulos DG; Husdan H; Harrison J; Meema HE; McNeill KG; Murray TM; Ogilvie R; Rapoport A
    Can Med Assoc J; 1977 Apr; 116(8):851-5. PubMed ID: 856428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.
    Ralston SH; Boyce BF; Cowan RA; Fogelman I; Smith ML; Jenkins A; Boyle IT
    J Bone Miner Res; 1987 Feb; 2(1):5-12. PubMed ID: 3137773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
    Stein I; Shapiro B; Ostrum B; Beller ML
    Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of the calcitonin test in Paget's disease of bone].
    D'Amore M; Bozzi A; Telesca ML; Carrozzo M
    Minerva Med; 1981 Apr; 72(14):865-8. PubMed ID: 7219796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
    Hosking DJ; Bijvoet OL
    Calcif Tissue Res; 1976 Aug; 21 Suppl():321-6. PubMed ID: 821599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.